Global Restless Legs Syndrome Market Growth (Status and Outlook) 2024-2030
The report requires updating with new data and is sent in 48 hours after order is placed.
According to our LPI (LP Information) latest study, the global Restless Legs Syndrome market size was valued at US$ million in 2023. With growing demand in downstream market, the Restless Legs Syndrome is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during review period.
The research report highlights the growth potential of the global Restless Legs Syndrome market. Restless Legs Syndrome are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Restless Legs Syndrome. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Restless Legs Syndrome market.
Restless legs syndrome (RLS) is a neurological disease. RLS is also called as Willis-Ekbom disease. Patients suffering from RLS disease have an irresistible desire to move their feet. The continual movement of the legs leads to pain in the limbs, which leads to the unusual sleep pattern of patients.
Global key players of Restless Legs Syndrome include Boehringer Ingelheim GmbH, UCB SA, Astellas, Arbor Pharmaceuticals, etc.
Boehringer Ingelheim GmbH is the largest manufacturers of Restless Legs Syndrome in the world, has a share about 70%.
Key Features:
The report on Restless Legs Syndrome market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the Restless Legs Syndrome market. It may include historical data, market segmentation by Type (e.g., Pharmacological Therapy, Non-Pharmacological Therapy), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Restless Legs Syndrome market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the Restless Legs Syndrome market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the Restless Legs Syndrome industry. This include advancements in Restless Legs Syndrome technology, Restless Legs Syndrome new entrants, Restless Legs Syndrome new investment, and other innovations that are shaping the future of Restless Legs Syndrome.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Restless Legs Syndrome market. It includes factors influencing customer ' purchasing decisions, preferences for Restless Legs Syndrome product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Restless Legs Syndrome market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Restless Legs Syndrome market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Restless Legs Syndrome market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Restless Legs Syndrome industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Restless Legs Syndrome market.
Market Segmentation:
Restless Legs Syndrome market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Segmentation by type
According to our LPI (LP Information) latest study, the global Restless Legs Syndrome market size was valued at US$ million in 2023. With growing demand in downstream market, the Restless Legs Syndrome is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during review period.
The research report highlights the growth potential of the global Restless Legs Syndrome market. Restless Legs Syndrome are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Restless Legs Syndrome. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Restless Legs Syndrome market.
Restless legs syndrome (RLS) is a neurological disease. RLS is also called as Willis-Ekbom disease. Patients suffering from RLS disease have an irresistible desire to move their feet. The continual movement of the legs leads to pain in the limbs, which leads to the unusual sleep pattern of patients.
Global key players of Restless Legs Syndrome include Boehringer Ingelheim GmbH, UCB SA, Astellas, Arbor Pharmaceuticals, etc.
Boehringer Ingelheim GmbH is the largest manufacturers of Restless Legs Syndrome in the world, has a share about 70%.
Key Features:
The report on Restless Legs Syndrome market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the Restless Legs Syndrome market. It may include historical data, market segmentation by Type (e.g., Pharmacological Therapy, Non-Pharmacological Therapy), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Restless Legs Syndrome market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the Restless Legs Syndrome market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the Restless Legs Syndrome industry. This include advancements in Restless Legs Syndrome technology, Restless Legs Syndrome new entrants, Restless Legs Syndrome new investment, and other innovations that are shaping the future of Restless Legs Syndrome.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Restless Legs Syndrome market. It includes factors influencing customer ' purchasing decisions, preferences for Restless Legs Syndrome product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Restless Legs Syndrome market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Restless Legs Syndrome market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Restless Legs Syndrome market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Restless Legs Syndrome industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Restless Legs Syndrome market.
Market Segmentation:
Restless Legs Syndrome market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Segmentation by type
- Pharmacological Therapy
- Non-Pharmacological Therapy
- Below 35 Years Old
- From 35 to 50 Years Old
- Above 50 Years Old
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Boehringer Ingelheim GmbH
- UCB SA
- Astellas
- Arbor Pharmaceuticals
- GlaxoSmithKline plc.
- Ligand Pharmaceuticals Incorporated
- axxonis Pharma AG
- Kyowa Hakko Kirin Co.
- Jazz Pharmaceuticals, Inc.
- Omeros Corporation
- Manhattan Pharmaceuticals
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Restless Legs Syndrome Market Size 2019-2030
2.1.2 Restless Legs Syndrome Market Size CAGR by Region 2019 VS 2023 VS 2030
2.2 Restless Legs Syndrome Segment by Type
2.2.1 Pharmacological Therapy
2.2.2 Non-Pharmacological Therapy
2.3 Restless Legs Syndrome Market Size by Type
2.3.1 Restless Legs Syndrome Market Size CAGR by Type (2019 VS 2023 VS 2030)
2.3.2 Global Restless Legs Syndrome Market Size Market Share by Type (2019-2024)
2.4 Restless Legs Syndrome Segment by Application
2.4.1 Below 35 Years Old
2.4.2 From 35 to 50 Years Old
2.4.3 Above 50 Years Old
2.5 Restless Legs Syndrome Market Size by Application
2.5.1 Restless Legs Syndrome Market Size CAGR by Application (2019 VS 2023 VS 2030)
2.5.2 Global Restless Legs Syndrome Market Size Market Share by Application (2019-2024)
3 RESTLESS LEGS SYNDROME MARKET SIZE BY PLAYER
3.1 Restless Legs Syndrome Market Size Market Share by Players
3.1.1 Global Restless Legs Syndrome Revenue by Players (2019-2024)
3.1.2 Global Restless Legs Syndrome Revenue Market Share by Players (2019-2024)
3.2 Global Restless Legs Syndrome Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 RESTLESS LEGS SYNDROME BY REGIONS
4.1 Restless Legs Syndrome Market Size by Regions (2019-2024)
4.2 Americas Restless Legs Syndrome Market Size Growth (2019-2024)
4.3 APAC Restless Legs Syndrome Market Size Growth (2019-2024)
4.4 Europe Restless Legs Syndrome Market Size Growth (2019-2024)
4.5 Middle East & Africa Restless Legs Syndrome Market Size Growth (2019-2024)
5 AMERICAS
5.1 Americas Restless Legs Syndrome Market Size by Country (2019-2024)
5.2 Americas Restless Legs Syndrome Market Size by Type (2019-2024)
5.3 Americas Restless Legs Syndrome Market Size by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Restless Legs Syndrome Market Size by Region (2019-2024)
6.2 APAC Restless Legs Syndrome Market Size by Type (2019-2024)
6.3 APAC Restless Legs Syndrome Market Size by Application (2019-2024)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Restless Legs Syndrome by Country (2019-2024)
7.2 Europe Restless Legs Syndrome Market Size by Type (2019-2024)
7.3 Europe Restless Legs Syndrome Market Size by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Restless Legs Syndrome by Region (2019-2024)
8.2 Middle East & Africa Restless Legs Syndrome Market Size by Type (2019-2024)
8.3 Middle East & Africa Restless Legs Syndrome Market Size by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL RESTLESS LEGS SYNDROME MARKET FORECAST
10.1 Global Restless Legs Syndrome Forecast by Regions (2025-2030)
10.1.1 Global Restless Legs Syndrome Forecast by Regions (2025-2030)
10.1.2 Americas Restless Legs Syndrome Forecast
10.1.3 APAC Restless Legs Syndrome Forecast
10.1.4 Europe Restless Legs Syndrome Forecast
10.1.5 Middle East & Africa Restless Legs Syndrome Forecast
10.2 Americas Restless Legs Syndrome Forecast by Country (2025-2030)
10.2.1 United States Restless Legs Syndrome Market Forecast
10.2.2 Canada Restless Legs Syndrome Market Forecast
10.2.3 Mexico Restless Legs Syndrome Market Forecast
10.2.4 Brazil Restless Legs Syndrome Market Forecast
10.3 APAC Restless Legs Syndrome Forecast by Region (2025-2030)
10.3.1 China Restless Legs Syndrome Market Forecast
10.3.2 Japan Restless Legs Syndrome Market Forecast
10.3.3 Korea Restless Legs Syndrome Market Forecast
10.3.4 Southeast Asia Restless Legs Syndrome Market Forecast
10.3.5 India Restless Legs Syndrome Market Forecast
10.3.6 Australia Restless Legs Syndrome Market Forecast
10.4 Europe Restless Legs Syndrome Forecast by Country (2025-2030)
10.4.1 Germany Restless Legs Syndrome Market Forecast
10.4.2 France Restless Legs Syndrome Market Forecast
10.4.3 UK Restless Legs Syndrome Market Forecast
10.4.4 Italy Restless Legs Syndrome Market Forecast
10.4.5 Russia Restless Legs Syndrome Market Forecast
10.5 Middle East & Africa Restless Legs Syndrome Forecast by Region (2025-2030)
10.5.1 Egypt Restless Legs Syndrome Market Forecast
10.5.2 South Africa Restless Legs Syndrome Market Forecast
10.5.3 Israel Restless Legs Syndrome Market Forecast
10.5.4 Turkey Restless Legs Syndrome Market Forecast
10.5.5 GCC Countries Restless Legs Syndrome Market Forecast
10.6 Global Restless Legs Syndrome Forecast by Type (2025-2030)
10.7 Global Restless Legs Syndrome Forecast by Application (2025-2030)
11 KEY PLAYERS ANALYSIS
11.1 Boehringer Ingelheim GmbH
11.1.1 Boehringer Ingelheim GmbH Company Information
11.1.2 Boehringer Ingelheim GmbH Restless Legs Syndrome Product Offered
11.1.3 Boehringer Ingelheim GmbH Restless Legs Syndrome Revenue, Gross Margin and Market Share (2019-2024)
11.1.4 Boehringer Ingelheim GmbH Main Business Overview
11.1.5 Boehringer Ingelheim GmbH Latest Developments
11.2 UCB SA
11.2.1 UCB SA Company Information
11.2.2 UCB SA Restless Legs Syndrome Product Offered
11.2.3 UCB SA Restless Legs Syndrome Revenue, Gross Margin and Market Share (2019-2024)
11.2.4 UCB SA Main Business Overview
11.2.5 UCB SA Latest Developments
11.3 Astellas
11.3.1 Astellas Company Information
11.3.2 Astellas Restless Legs Syndrome Product Offered
11.3.3 Astellas Restless Legs Syndrome Revenue, Gross Margin and Market Share (2019-2024)
11.3.4 Astellas Main Business Overview
11.3.5 Astellas Latest Developments
11.4 Arbor Pharmaceuticals
11.4.1 Arbor Pharmaceuticals Company Information
11.4.2 Arbor Pharmaceuticals Restless Legs Syndrome Product Offered
11.4.3 Arbor Pharmaceuticals Restless Legs Syndrome Revenue, Gross Margin and Market Share (2019-2024)
11.4.4 Arbor Pharmaceuticals Main Business Overview
11.4.5 Arbor Pharmaceuticals Latest Developments
11.5 GlaxoSmithKline plc.
11.5.1 GlaxoSmithKline plc. Company Information
11.5.2 GlaxoSmithKline plc. Restless Legs Syndrome Product Offered
11.5.3 GlaxoSmithKline plc. Restless Legs Syndrome Revenue, Gross Margin and Market Share (2019-2024)
11.5.4 GlaxoSmithKline plc. Main Business Overview
11.5.5 GlaxoSmithKline plc. Latest Developments
11.6 Ligand Pharmaceuticals Incorporated
11.6.1 Ligand Pharmaceuticals Incorporated Company Information
11.6.2 Ligand Pharmaceuticals Incorporated Restless Legs Syndrome Product Offered
11.6.3 Ligand Pharmaceuticals Incorporated Restless Legs Syndrome Revenue, Gross Margin and Market Share (2019-2024)
11.6.4 Ligand Pharmaceuticals Incorporated Main Business Overview
11.6.5 Ligand Pharmaceuticals Incorporated Latest Developments
11.7 axxonis Pharma AG
11.7.1 axxonis Pharma AG Company Information
11.7.2 axxonis Pharma AG Restless Legs Syndrome Product Offered
11.7.3 axxonis Pharma AG Restless Legs Syndrome Revenue, Gross Margin and Market Share (2019-2024)
11.7.4 axxonis Pharma AG Main Business Overview
11.7.5 axxonis Pharma AG Latest Developments
11.8 Kyowa Hakko Kirin Co.
11.8.1 Kyowa Hakko Kirin Co. Company Information
11.8.2 Kyowa Hakko Kirin Co. Restless Legs Syndrome Product Offered
11.8.3 Kyowa Hakko Kirin Co. Restless Legs Syndrome Revenue, Gross Margin and Market Share (2019-2024)
11.8.4 Kyowa Hakko Kirin Co. Main Business Overview
11.8.5 Kyowa Hakko Kirin Co. Latest Developments
11.9 Jazz Pharmaceuticals, Inc.
11.9.1 Jazz Pharmaceuticals, Inc. Company Information
11.9.2 Jazz Pharmaceuticals, Inc. Restless Legs Syndrome Product Offered
11.9.3 Jazz Pharmaceuticals, Inc. Restless Legs Syndrome Revenue, Gross Margin and Market Share (2019-2024)
11.9.4 Jazz Pharmaceuticals, Inc. Main Business Overview
11.9.5 Jazz Pharmaceuticals, Inc. Latest Developments
11.10 Omeros Corporation
11.10.1 Omeros Corporation Company Information
11.10.2 Omeros Corporation Restless Legs Syndrome Product Offered
11.10.3 Omeros Corporation Restless Legs Syndrome Revenue, Gross Margin and Market Share (2019-2024)
11.10.4 Omeros Corporation Main Business Overview
11.10.5 Omeros Corporation Latest Developments
11.11 Manhattan Pharmaceuticals
11.11.1 Manhattan Pharmaceuticals Company Information
11.11.2 Manhattan Pharmaceuticals Restless Legs Syndrome Product Offered
11.11.3 Manhattan Pharmaceuticals Restless Legs Syndrome Revenue, Gross Margin and Market Share (2019-2024)
11.11.4 Manhattan Pharmaceuticals Main Business Overview
11.11.5 Manhattan Pharmaceuticals Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Restless Legs Syndrome Market Size 2019-2030
2.1.2 Restless Legs Syndrome Market Size CAGR by Region 2019 VS 2023 VS 2030
2.2 Restless Legs Syndrome Segment by Type
2.2.1 Pharmacological Therapy
2.2.2 Non-Pharmacological Therapy
2.3 Restless Legs Syndrome Market Size by Type
2.3.1 Restless Legs Syndrome Market Size CAGR by Type (2019 VS 2023 VS 2030)
2.3.2 Global Restless Legs Syndrome Market Size Market Share by Type (2019-2024)
2.4 Restless Legs Syndrome Segment by Application
2.4.1 Below 35 Years Old
2.4.2 From 35 to 50 Years Old
2.4.3 Above 50 Years Old
2.5 Restless Legs Syndrome Market Size by Application
2.5.1 Restless Legs Syndrome Market Size CAGR by Application (2019 VS 2023 VS 2030)
2.5.2 Global Restless Legs Syndrome Market Size Market Share by Application (2019-2024)
3 RESTLESS LEGS SYNDROME MARKET SIZE BY PLAYER
3.1 Restless Legs Syndrome Market Size Market Share by Players
3.1.1 Global Restless Legs Syndrome Revenue by Players (2019-2024)
3.1.2 Global Restless Legs Syndrome Revenue Market Share by Players (2019-2024)
3.2 Global Restless Legs Syndrome Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 RESTLESS LEGS SYNDROME BY REGIONS
4.1 Restless Legs Syndrome Market Size by Regions (2019-2024)
4.2 Americas Restless Legs Syndrome Market Size Growth (2019-2024)
4.3 APAC Restless Legs Syndrome Market Size Growth (2019-2024)
4.4 Europe Restless Legs Syndrome Market Size Growth (2019-2024)
4.5 Middle East & Africa Restless Legs Syndrome Market Size Growth (2019-2024)
5 AMERICAS
5.1 Americas Restless Legs Syndrome Market Size by Country (2019-2024)
5.2 Americas Restless Legs Syndrome Market Size by Type (2019-2024)
5.3 Americas Restless Legs Syndrome Market Size by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Restless Legs Syndrome Market Size by Region (2019-2024)
6.2 APAC Restless Legs Syndrome Market Size by Type (2019-2024)
6.3 APAC Restless Legs Syndrome Market Size by Application (2019-2024)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Restless Legs Syndrome by Country (2019-2024)
7.2 Europe Restless Legs Syndrome Market Size by Type (2019-2024)
7.3 Europe Restless Legs Syndrome Market Size by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Restless Legs Syndrome by Region (2019-2024)
8.2 Middle East & Africa Restless Legs Syndrome Market Size by Type (2019-2024)
8.3 Middle East & Africa Restless Legs Syndrome Market Size by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL RESTLESS LEGS SYNDROME MARKET FORECAST
10.1 Global Restless Legs Syndrome Forecast by Regions (2025-2030)
10.1.1 Global Restless Legs Syndrome Forecast by Regions (2025-2030)
10.1.2 Americas Restless Legs Syndrome Forecast
10.1.3 APAC Restless Legs Syndrome Forecast
10.1.4 Europe Restless Legs Syndrome Forecast
10.1.5 Middle East & Africa Restless Legs Syndrome Forecast
10.2 Americas Restless Legs Syndrome Forecast by Country (2025-2030)
10.2.1 United States Restless Legs Syndrome Market Forecast
10.2.2 Canada Restless Legs Syndrome Market Forecast
10.2.3 Mexico Restless Legs Syndrome Market Forecast
10.2.4 Brazil Restless Legs Syndrome Market Forecast
10.3 APAC Restless Legs Syndrome Forecast by Region (2025-2030)
10.3.1 China Restless Legs Syndrome Market Forecast
10.3.2 Japan Restless Legs Syndrome Market Forecast
10.3.3 Korea Restless Legs Syndrome Market Forecast
10.3.4 Southeast Asia Restless Legs Syndrome Market Forecast
10.3.5 India Restless Legs Syndrome Market Forecast
10.3.6 Australia Restless Legs Syndrome Market Forecast
10.4 Europe Restless Legs Syndrome Forecast by Country (2025-2030)
10.4.1 Germany Restless Legs Syndrome Market Forecast
10.4.2 France Restless Legs Syndrome Market Forecast
10.4.3 UK Restless Legs Syndrome Market Forecast
10.4.4 Italy Restless Legs Syndrome Market Forecast
10.4.5 Russia Restless Legs Syndrome Market Forecast
10.5 Middle East & Africa Restless Legs Syndrome Forecast by Region (2025-2030)
10.5.1 Egypt Restless Legs Syndrome Market Forecast
10.5.2 South Africa Restless Legs Syndrome Market Forecast
10.5.3 Israel Restless Legs Syndrome Market Forecast
10.5.4 Turkey Restless Legs Syndrome Market Forecast
10.5.5 GCC Countries Restless Legs Syndrome Market Forecast
10.6 Global Restless Legs Syndrome Forecast by Type (2025-2030)
10.7 Global Restless Legs Syndrome Forecast by Application (2025-2030)
11 KEY PLAYERS ANALYSIS
11.1 Boehringer Ingelheim GmbH
11.1.1 Boehringer Ingelheim GmbH Company Information
11.1.2 Boehringer Ingelheim GmbH Restless Legs Syndrome Product Offered
11.1.3 Boehringer Ingelheim GmbH Restless Legs Syndrome Revenue, Gross Margin and Market Share (2019-2024)
11.1.4 Boehringer Ingelheim GmbH Main Business Overview
11.1.5 Boehringer Ingelheim GmbH Latest Developments
11.2 UCB SA
11.2.1 UCB SA Company Information
11.2.2 UCB SA Restless Legs Syndrome Product Offered
11.2.3 UCB SA Restless Legs Syndrome Revenue, Gross Margin and Market Share (2019-2024)
11.2.4 UCB SA Main Business Overview
11.2.5 UCB SA Latest Developments
11.3 Astellas
11.3.1 Astellas Company Information
11.3.2 Astellas Restless Legs Syndrome Product Offered
11.3.3 Astellas Restless Legs Syndrome Revenue, Gross Margin and Market Share (2019-2024)
11.3.4 Astellas Main Business Overview
11.3.5 Astellas Latest Developments
11.4 Arbor Pharmaceuticals
11.4.1 Arbor Pharmaceuticals Company Information
11.4.2 Arbor Pharmaceuticals Restless Legs Syndrome Product Offered
11.4.3 Arbor Pharmaceuticals Restless Legs Syndrome Revenue, Gross Margin and Market Share (2019-2024)
11.4.4 Arbor Pharmaceuticals Main Business Overview
11.4.5 Arbor Pharmaceuticals Latest Developments
11.5 GlaxoSmithKline plc.
11.5.1 GlaxoSmithKline plc. Company Information
11.5.2 GlaxoSmithKline plc. Restless Legs Syndrome Product Offered
11.5.3 GlaxoSmithKline plc. Restless Legs Syndrome Revenue, Gross Margin and Market Share (2019-2024)
11.5.4 GlaxoSmithKline plc. Main Business Overview
11.5.5 GlaxoSmithKline plc. Latest Developments
11.6 Ligand Pharmaceuticals Incorporated
11.6.1 Ligand Pharmaceuticals Incorporated Company Information
11.6.2 Ligand Pharmaceuticals Incorporated Restless Legs Syndrome Product Offered
11.6.3 Ligand Pharmaceuticals Incorporated Restless Legs Syndrome Revenue, Gross Margin and Market Share (2019-2024)
11.6.4 Ligand Pharmaceuticals Incorporated Main Business Overview
11.6.5 Ligand Pharmaceuticals Incorporated Latest Developments
11.7 axxonis Pharma AG
11.7.1 axxonis Pharma AG Company Information
11.7.2 axxonis Pharma AG Restless Legs Syndrome Product Offered
11.7.3 axxonis Pharma AG Restless Legs Syndrome Revenue, Gross Margin and Market Share (2019-2024)
11.7.4 axxonis Pharma AG Main Business Overview
11.7.5 axxonis Pharma AG Latest Developments
11.8 Kyowa Hakko Kirin Co.
11.8.1 Kyowa Hakko Kirin Co. Company Information
11.8.2 Kyowa Hakko Kirin Co. Restless Legs Syndrome Product Offered
11.8.3 Kyowa Hakko Kirin Co. Restless Legs Syndrome Revenue, Gross Margin and Market Share (2019-2024)
11.8.4 Kyowa Hakko Kirin Co. Main Business Overview
11.8.5 Kyowa Hakko Kirin Co. Latest Developments
11.9 Jazz Pharmaceuticals, Inc.
11.9.1 Jazz Pharmaceuticals, Inc. Company Information
11.9.2 Jazz Pharmaceuticals, Inc. Restless Legs Syndrome Product Offered
11.9.3 Jazz Pharmaceuticals, Inc. Restless Legs Syndrome Revenue, Gross Margin and Market Share (2019-2024)
11.9.4 Jazz Pharmaceuticals, Inc. Main Business Overview
11.9.5 Jazz Pharmaceuticals, Inc. Latest Developments
11.10 Omeros Corporation
11.10.1 Omeros Corporation Company Information
11.10.2 Omeros Corporation Restless Legs Syndrome Product Offered
11.10.3 Omeros Corporation Restless Legs Syndrome Revenue, Gross Margin and Market Share (2019-2024)
11.10.4 Omeros Corporation Main Business Overview
11.10.5 Omeros Corporation Latest Developments
11.11 Manhattan Pharmaceuticals
11.11.1 Manhattan Pharmaceuticals Company Information
11.11.2 Manhattan Pharmaceuticals Restless Legs Syndrome Product Offered
11.11.3 Manhattan Pharmaceuticals Restless Legs Syndrome Revenue, Gross Margin and Market Share (2019-2024)
11.11.4 Manhattan Pharmaceuticals Main Business Overview
11.11.5 Manhattan Pharmaceuticals Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Restless Legs Syndrome Market Size CAGR by Region (2019 VS 2023 VS 2030) & ($ Millions)
Table 2. Major Players of Pharmacological Therapy
Table 3. Major Players of Non-Pharmacological Therapy
Table 4. Restless Legs Syndrome Market Size CAGR by Type (2019 VS 2023 VS 2030) & ($ Millions)
Table 5. Global Restless Legs Syndrome Market Size by Type (2019-2024) & ($ Millions)
Table 6. Global Restless Legs Syndrome Market Size Market Share by Type (2019-2024)
Table 7. Restless Legs Syndrome Market Size CAGR by Application (2019 VS 2023 VS 2030) & ($ Millions)
Table 8. Global Restless Legs Syndrome Market Size by Application (2019-2024) & ($ Millions)
Table 9. Global Restless Legs Syndrome Market Size Market Share by Application (2019-2024)
Table 10. Global Restless Legs Syndrome Revenue by Players (2019-2024) & ($ Millions)
Table 11. Global Restless Legs Syndrome Revenue Market Share by Player (2019-2024)
Table 12. Restless Legs Syndrome Key Players Head office and Products Offered
Table 13. Restless Legs Syndrome Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
Table 14. New Products and Potential Entrants
Table 15. Mergers & Acquisitions, Expansion
Table 16. Global Restless Legs Syndrome Market Size by Regions 2019-2024 & ($ Millions)
Table 17. Global Restless Legs Syndrome Market Size Market Share by Regions (2019-2024)
Table 18. Global Restless Legs Syndrome Revenue by Country/Region (2019-2024) & ($ millions)
Table 19. Global Restless Legs Syndrome Revenue Market Share by Country/Region (2019-2024)
Table 20. Americas Restless Legs Syndrome Market Size by Country (2019-2024) & ($ Millions)
Table 21. Americas Restless Legs Syndrome Market Size Market Share by Country (2019-2024)
Table 22. Americas Restless Legs Syndrome Market Size by Type (2019-2024) & ($ Millions)
Table 23. Americas Restless Legs Syndrome Market Size Market Share by Type (2019-2024)
Table 24. Americas Restless Legs Syndrome Market Size by Application (2019-2024) & ($ Millions)
Table 25. Americas Restless Legs Syndrome Market Size Market Share by Application (2019-2024)
Table 26. APAC Restless Legs Syndrome Market Size by Region (2019-2024) & ($ Millions)
Table 27. APAC Restless Legs Syndrome Market Size Market Share by Region (2019-2024)
Table 28. APAC Restless Legs Syndrome Market Size by Type (2019-2024) & ($ Millions)
Table 29. APAC Restless Legs Syndrome Market Size Market Share by Type (2019-2024)
Table 30. APAC Restless Legs Syndrome Market Size by Application (2019-2024) & ($ Millions)
Table 31. APAC Restless Legs Syndrome Market Size Market Share by Application (2019-2024)
Table 32. Europe Restless Legs Syndrome Market Size by Country (2019-2024) & ($ Millions)
Table 33. Europe Restless Legs Syndrome Market Size Market Share by Country (2019-2024)
Table 34. Europe Restless Legs Syndrome Market Size by Type (2019-2024) & ($ Millions)
Table 35. Europe Restless Legs Syndrome Market Size Market Share by Type (2019-2024)
Table 36. Europe Restless Legs Syndrome Market Size by Application (2019-2024) & ($ Millions)
Table 37. Europe Restless Legs Syndrome Market Size Market Share by Application (2019-2024)
Table 38. Middle East & Africa Restless Legs Syndrome Market Size by Region (2019-2024) & ($ Millions)
Table 39. Middle East & Africa Restless Legs Syndrome Market Size Market Share by Region (2019-2024)
Table 40. Middle East & Africa Restless Legs Syndrome Market Size by Type (2019-2024) & ($ Millions)
Table 41. Middle East & Africa Restless Legs Syndrome Market Size Market Share by Type (2019-2024)
Table 42. Middle East & Africa Restless Legs Syndrome Market Size by Application (2019-2024) & ($ Millions)
Table 43. Middle East & Africa Restless Legs Syndrome Market Size Market Share by Application (2019-2024)
Table 44. Key Market Drivers & Growth Opportunities of Restless Legs Syndrome
Table 45. Key Market Challenges & Risks of Restless Legs Syndrome
Table 46. Key Industry Trends of Restless Legs Syndrome
Table 47. Global Restless Legs Syndrome Market Size Forecast by Regions (2025-2030) & ($ Millions)
Table 48. Global Restless Legs Syndrome Market Size Market Share Forecast by Regions (2025-2030)
Table 49. Global Restless Legs Syndrome Market Size Forecast by Type (2025-2030) & ($ Millions)
Table 50. Global Restless Legs Syndrome Market Size Forecast by Application (2025-2030) & ($ Millions)
Table 51. Boehringer Ingelheim GmbH Details, Company Type, Restless Legs Syndrome Area Served and Its Competitors
Table 52. Boehringer Ingelheim GmbH Restless Legs Syndrome Product Offered
Table 53. Boehringer Ingelheim GmbH Restless Legs Syndrome Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 54. Boehringer Ingelheim GmbH Main Business
Table 55. Boehringer Ingelheim GmbH Latest Developments
Table 56. UCB SA Details, Company Type, Restless Legs Syndrome Area Served and Its Competitors
Table 57. UCB SA Restless Legs Syndrome Product Offered
Table 58. UCB SA Main Business
Table 59. UCB SA Restless Legs Syndrome Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 60. UCB SA Latest Developments
Table 61. Astellas Details, Company Type, Restless Legs Syndrome Area Served and Its Competitors
Table 62. Astellas Restless Legs Syndrome Product Offered
Table 63. Astellas Main Business
Table 64. Astellas Restless Legs Syndrome Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 65. Astellas Latest Developments
Table 66. Arbor Pharmaceuticals Details, Company Type, Restless Legs Syndrome Area Served and Its Competitors
Table 67. Arbor Pharmaceuticals Restless Legs Syndrome Product Offered
Table 68. Arbor Pharmaceuticals Main Business
Table 69. Arbor Pharmaceuticals Restless Legs Syndrome Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 70. Arbor Pharmaceuticals Latest Developments
Table 71. GlaxoSmithKline plc. Details, Company Type, Restless Legs Syndrome Area Served and Its Competitors
Table 72. GlaxoSmithKline plc. Restless Legs Syndrome Product Offered
Table 73. GlaxoSmithKline plc. Main Business
Table 74. GlaxoSmithKline plc. Restless Legs Syndrome Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 75. GlaxoSmithKline plc. Latest Developments
Table 76. Ligand Pharmaceuticals Incorporated Details, Company Type, Restless Legs Syndrome Area Served and Its Competitors
Table 77. Ligand Pharmaceuticals Incorporated Restless Legs Syndrome Product Offered
Table 78. Ligand Pharmaceuticals Incorporated Main Business
Table 79. Ligand Pharmaceuticals Incorporated Restless Legs Syndrome Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 80. Ligand Pharmaceuticals Incorporated Latest Developments
Table 81. axxonis Pharma AG Details, Company Type, Restless Legs Syndrome Area Served and Its Competitors
Table 82. axxonis Pharma AG Restless Legs Syndrome Product Offered
Table 83. axxonis Pharma AG Main Business
Table 84. axxonis Pharma AG Restless Legs Syndrome Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 85. axxonis Pharma AG Latest Developments
Table 86. Kyowa Hakko Kirin Co. Details, Company Type, Restless Legs Syndrome Area Served and Its Competitors
Table 87. Kyowa Hakko Kirin Co. Restless Legs Syndrome Product Offered
Table 88. Kyowa Hakko Kirin Co. Main Business
Table 89. Kyowa Hakko Kirin Co. Restless Legs Syndrome Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 90. Kyowa Hakko Kirin Co. Latest Developments
Table 91. Jazz Pharmaceuticals, Inc. Details, Company Type, Restless Legs Syndrome Area Served and Its Competitors
Table 92. Jazz Pharmaceuticals, Inc. Restless Legs Syndrome Product Offered
Table 93. Jazz Pharmaceuticals, Inc. Main Business
Table 94. Jazz Pharmaceuticals, Inc. Restless Legs Syndrome Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 95. Jazz Pharmaceuticals, Inc. Latest Developments
Table 96. Omeros Corporation Details, Company Type, Restless Legs Syndrome Area Served and Its Competitors
Table 97. Omeros Corporation Restless Legs Syndrome Product Offered
Table 98. Omeros Corporation Main Business
Table 99. Omeros Corporation Restless Legs Syndrome Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 100. Omeros Corporation Latest Developments
Table 101. Manhattan Pharmaceuticals Details, Company Type, Restless Legs Syndrome Area Served and Its Competitors
Table 102. Manhattan Pharmaceuticals Restless Legs Syndrome Product Offered
Table 103. Manhattan Pharmaceuticals Restless Legs Syndrome Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 104. Manhattan Pharmaceuticals Main Business
Table 105. Manhattan Pharmaceuticals Latest Developments
Table 1. Restless Legs Syndrome Market Size CAGR by Region (2019 VS 2023 VS 2030) & ($ Millions)
Table 2. Major Players of Pharmacological Therapy
Table 3. Major Players of Non-Pharmacological Therapy
Table 4. Restless Legs Syndrome Market Size CAGR by Type (2019 VS 2023 VS 2030) & ($ Millions)
Table 5. Global Restless Legs Syndrome Market Size by Type (2019-2024) & ($ Millions)
Table 6. Global Restless Legs Syndrome Market Size Market Share by Type (2019-2024)
Table 7. Restless Legs Syndrome Market Size CAGR by Application (2019 VS 2023 VS 2030) & ($ Millions)
Table 8. Global Restless Legs Syndrome Market Size by Application (2019-2024) & ($ Millions)
Table 9. Global Restless Legs Syndrome Market Size Market Share by Application (2019-2024)
Table 10. Global Restless Legs Syndrome Revenue by Players (2019-2024) & ($ Millions)
Table 11. Global Restless Legs Syndrome Revenue Market Share by Player (2019-2024)
Table 12. Restless Legs Syndrome Key Players Head office and Products Offered
Table 13. Restless Legs Syndrome Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
Table 14. New Products and Potential Entrants
Table 15. Mergers & Acquisitions, Expansion
Table 16. Global Restless Legs Syndrome Market Size by Regions 2019-2024 & ($ Millions)
Table 17. Global Restless Legs Syndrome Market Size Market Share by Regions (2019-2024)
Table 18. Global Restless Legs Syndrome Revenue by Country/Region (2019-2024) & ($ millions)
Table 19. Global Restless Legs Syndrome Revenue Market Share by Country/Region (2019-2024)
Table 20. Americas Restless Legs Syndrome Market Size by Country (2019-2024) & ($ Millions)
Table 21. Americas Restless Legs Syndrome Market Size Market Share by Country (2019-2024)
Table 22. Americas Restless Legs Syndrome Market Size by Type (2019-2024) & ($ Millions)
Table 23. Americas Restless Legs Syndrome Market Size Market Share by Type (2019-2024)
Table 24. Americas Restless Legs Syndrome Market Size by Application (2019-2024) & ($ Millions)
Table 25. Americas Restless Legs Syndrome Market Size Market Share by Application (2019-2024)
Table 26. APAC Restless Legs Syndrome Market Size by Region (2019-2024) & ($ Millions)
Table 27. APAC Restless Legs Syndrome Market Size Market Share by Region (2019-2024)
Table 28. APAC Restless Legs Syndrome Market Size by Type (2019-2024) & ($ Millions)
Table 29. APAC Restless Legs Syndrome Market Size Market Share by Type (2019-2024)
Table 30. APAC Restless Legs Syndrome Market Size by Application (2019-2024) & ($ Millions)
Table 31. APAC Restless Legs Syndrome Market Size Market Share by Application (2019-2024)
Table 32. Europe Restless Legs Syndrome Market Size by Country (2019-2024) & ($ Millions)
Table 33. Europe Restless Legs Syndrome Market Size Market Share by Country (2019-2024)
Table 34. Europe Restless Legs Syndrome Market Size by Type (2019-2024) & ($ Millions)
Table 35. Europe Restless Legs Syndrome Market Size Market Share by Type (2019-2024)
Table 36. Europe Restless Legs Syndrome Market Size by Application (2019-2024) & ($ Millions)
Table 37. Europe Restless Legs Syndrome Market Size Market Share by Application (2019-2024)
Table 38. Middle East & Africa Restless Legs Syndrome Market Size by Region (2019-2024) & ($ Millions)
Table 39. Middle East & Africa Restless Legs Syndrome Market Size Market Share by Region (2019-2024)
Table 40. Middle East & Africa Restless Legs Syndrome Market Size by Type (2019-2024) & ($ Millions)
Table 41. Middle East & Africa Restless Legs Syndrome Market Size Market Share by Type (2019-2024)
Table 42. Middle East & Africa Restless Legs Syndrome Market Size by Application (2019-2024) & ($ Millions)
Table 43. Middle East & Africa Restless Legs Syndrome Market Size Market Share by Application (2019-2024)
Table 44. Key Market Drivers & Growth Opportunities of Restless Legs Syndrome
Table 45. Key Market Challenges & Risks of Restless Legs Syndrome
Table 46. Key Industry Trends of Restless Legs Syndrome
Table 47. Global Restless Legs Syndrome Market Size Forecast by Regions (2025-2030) & ($ Millions)
Table 48. Global Restless Legs Syndrome Market Size Market Share Forecast by Regions (2025-2030)
Table 49. Global Restless Legs Syndrome Market Size Forecast by Type (2025-2030) & ($ Millions)
Table 50. Global Restless Legs Syndrome Market Size Forecast by Application (2025-2030) & ($ Millions)
Table 51. Boehringer Ingelheim GmbH Details, Company Type, Restless Legs Syndrome Area Served and Its Competitors
Table 52. Boehringer Ingelheim GmbH Restless Legs Syndrome Product Offered
Table 53. Boehringer Ingelheim GmbH Restless Legs Syndrome Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 54. Boehringer Ingelheim GmbH Main Business
Table 55. Boehringer Ingelheim GmbH Latest Developments
Table 56. UCB SA Details, Company Type, Restless Legs Syndrome Area Served and Its Competitors
Table 57. UCB SA Restless Legs Syndrome Product Offered
Table 58. UCB SA Main Business
Table 59. UCB SA Restless Legs Syndrome Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 60. UCB SA Latest Developments
Table 61. Astellas Details, Company Type, Restless Legs Syndrome Area Served and Its Competitors
Table 62. Astellas Restless Legs Syndrome Product Offered
Table 63. Astellas Main Business
Table 64. Astellas Restless Legs Syndrome Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 65. Astellas Latest Developments
Table 66. Arbor Pharmaceuticals Details, Company Type, Restless Legs Syndrome Area Served and Its Competitors
Table 67. Arbor Pharmaceuticals Restless Legs Syndrome Product Offered
Table 68. Arbor Pharmaceuticals Main Business
Table 69. Arbor Pharmaceuticals Restless Legs Syndrome Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 70. Arbor Pharmaceuticals Latest Developments
Table 71. GlaxoSmithKline plc. Details, Company Type, Restless Legs Syndrome Area Served and Its Competitors
Table 72. GlaxoSmithKline plc. Restless Legs Syndrome Product Offered
Table 73. GlaxoSmithKline plc. Main Business
Table 74. GlaxoSmithKline plc. Restless Legs Syndrome Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 75. GlaxoSmithKline plc. Latest Developments
Table 76. Ligand Pharmaceuticals Incorporated Details, Company Type, Restless Legs Syndrome Area Served and Its Competitors
Table 77. Ligand Pharmaceuticals Incorporated Restless Legs Syndrome Product Offered
Table 78. Ligand Pharmaceuticals Incorporated Main Business
Table 79. Ligand Pharmaceuticals Incorporated Restless Legs Syndrome Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 80. Ligand Pharmaceuticals Incorporated Latest Developments
Table 81. axxonis Pharma AG Details, Company Type, Restless Legs Syndrome Area Served and Its Competitors
Table 82. axxonis Pharma AG Restless Legs Syndrome Product Offered
Table 83. axxonis Pharma AG Main Business
Table 84. axxonis Pharma AG Restless Legs Syndrome Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 85. axxonis Pharma AG Latest Developments
Table 86. Kyowa Hakko Kirin Co. Details, Company Type, Restless Legs Syndrome Area Served and Its Competitors
Table 87. Kyowa Hakko Kirin Co. Restless Legs Syndrome Product Offered
Table 88. Kyowa Hakko Kirin Co. Main Business
Table 89. Kyowa Hakko Kirin Co. Restless Legs Syndrome Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 90. Kyowa Hakko Kirin Co. Latest Developments
Table 91. Jazz Pharmaceuticals, Inc. Details, Company Type, Restless Legs Syndrome Area Served and Its Competitors
Table 92. Jazz Pharmaceuticals, Inc. Restless Legs Syndrome Product Offered
Table 93. Jazz Pharmaceuticals, Inc. Main Business
Table 94. Jazz Pharmaceuticals, Inc. Restless Legs Syndrome Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 95. Jazz Pharmaceuticals, Inc. Latest Developments
Table 96. Omeros Corporation Details, Company Type, Restless Legs Syndrome Area Served and Its Competitors
Table 97. Omeros Corporation Restless Legs Syndrome Product Offered
Table 98. Omeros Corporation Main Business
Table 99. Omeros Corporation Restless Legs Syndrome Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 100. Omeros Corporation Latest Developments
Table 101. Manhattan Pharmaceuticals Details, Company Type, Restless Legs Syndrome Area Served and Its Competitors
Table 102. Manhattan Pharmaceuticals Restless Legs Syndrome Product Offered
Table 103. Manhattan Pharmaceuticals Restless Legs Syndrome Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 104. Manhattan Pharmaceuticals Main Business
Table 105. Manhattan Pharmaceuticals Latest Developments
LIST OF FIGURES
Figure 1. Restless Legs Syndrome Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Restless Legs Syndrome Market Size Growth Rate 2019-2030 ($ Millions)
Figure 6. Restless Legs Syndrome Sales by Geographic Region (2019, 2023 & 2030) & ($ millions)
Figure 7. Restless Legs Syndrome Sales Market Share by Country/Region (2023)
Figure 8. Restless Legs Syndrome Sales Market Share by Country/Region (2019, 2023 & 2030)
Figure 9. Global Restless Legs Syndrome Market Size Market Share by Type in 2023
Figure 10. Restless Legs Syndrome in Below 35 Years Old
Figure 11. Global Restless Legs Syndrome Market: Below 35 Years Old (2019-2024) & ($ Millions)
Figure 12. Restless Legs Syndrome in From 35 to 50 Years Old
Figure 13. Global Restless Legs Syndrome Market: From 35 to 50 Years Old (2019-2024) & ($ Millions)
Figure 14. Restless Legs Syndrome in Above 50 Years Old
Figure 15. Global Restless Legs Syndrome Market: Above 50 Years Old (2019-2024) & ($ Millions)
Figure 16. Global Restless Legs Syndrome Market Size Market Share by Application in 2023
Figure 17. Global Restless Legs Syndrome Revenue Market Share by Player in 2023
Figure 18. Global Restless Legs Syndrome Market Size Market Share by Regions (2019-2024)
Figure 19. Americas Restless Legs Syndrome Market Size 2019-2024 ($ Millions)
Figure 20. APAC Restless Legs Syndrome Market Size 2019-2024 ($ Millions)
Figure 21. Europe Restless Legs Syndrome Market Size 2019-2024 ($ Millions)
Figure 22. Middle East & Africa Restless Legs Syndrome Market Size 2019-2024 ($ Millions)
Figure 23. Americas Restless Legs Syndrome Value Market Share by Country in 2023
Figure 24. United States Restless Legs Syndrome Market Size Growth 2019-2024 ($ Millions)
Figure 25. Canada Restless Legs Syndrome Market Size Growth 2019-2024 ($ Millions)
Figure 26. Mexico Restless Legs Syndrome Market Size Growth 2019-2024 ($ Millions)
Figure 27. Brazil Restless Legs Syndrome Market Size Growth 2019-2024 ($ Millions)
Figure 28. APAC Restless Legs Syndrome Market Size Market Share by Region in 2023
Figure 29. APAC Restless Legs Syndrome Market Size Market Share by Type in 2023
Figure 30. APAC Restless Legs Syndrome Market Size Market Share by Application in 2023
Figure 31. China Restless Legs Syndrome Market Size Growth 2019-2024 ($ Millions)
Figure 32. Japan Restless Legs Syndrome Market Size Growth 2019-2024 ($ Millions)
Figure 33. Korea Restless Legs Syndrome Market Size Growth 2019-2024 ($ Millions)
Figure 34. Southeast Asia Restless Legs Syndrome Market Size Growth 2019-2024 ($ Millions)
Figure 35. India Restless Legs Syndrome Market Size Growth 2019-2024 ($ Millions)
Figure 36. Australia Restless Legs Syndrome Market Size Growth 2019-2024 ($ Millions)
Figure 37. Europe Restless Legs Syndrome Market Size Market Share by Country in 2023
Figure 38. Europe Restless Legs Syndrome Market Size Market Share by Type (2019-2024)
Figure 39. Europe Restless Legs Syndrome Market Size Market Share by Application (2019-2024)
Figure 40. Germany Restless Legs Syndrome Market Size Growth 2019-2024 ($ Millions)
Figure 41. France Restless Legs Syndrome Market Size Growth 2019-2024 ($ Millions)
Figure 42. UK Restless Legs Syndrome Market Size Growth 2019-2024 ($ Millions)
Figure 43. Italy Restless Legs Syndrome Market Size Growth 2019-2024 ($ Millions)
Figure 44. Russia Restless Legs Syndrome Market Size Growth 2019-2024 ($ Millions)
Figure 45. Middle East & Africa Restless Legs Syndrome Market Size Market Share by Region (2019-2024)
Figure 46. Middle East & Africa Restless Legs Syndrome Market Size Market Share by Type (2019-2024)
Figure 47. Middle East & Africa Restless Legs Syndrome Market Size Market Share by Application (2019-2024)
Figure 48. Egypt Restless Legs Syndrome Market Size Growth 2019-2024 ($ Millions)
Figure 49. South Africa Restless Legs Syndrome Market Size Growth 2019-2024 ($ Millions)
Figure 50. Israel Restless Legs Syndrome Market Size Growth 2019-2024 ($ Millions)
Figure 51. Turkey Restless Legs Syndrome Market Size Growth 2019-2024 ($ Millions)
Figure 52. GCC Country Restless Legs Syndrome Market Size Growth 2019-2024 ($ Millions)
Figure 53. Americas Restless Legs Syndrome Market Size 2025-2030 ($ Millions)
Figure 54. APAC Restless Legs Syndrome Market Size 2025-2030 ($ Millions)
Figure 55. Europe Restless Legs Syndrome Market Size 2025-2030 ($ Millions)
Figure 56. Middle East & Africa Restless Legs Syndrome Market Size 2025-2030 ($ Millions)
Figure 57. United States Restless Legs Syndrome Market Size 2025-2030 ($ Millions)
Figure 58. Canada Restless Legs Syndrome Market Size 2025-2030 ($ Millions)
Figure 59. Mexico Restless Legs Syndrome Market Size 2025-2030 ($ Millions)
Figure 60. Brazil Restless Legs Syndrome Market Size 2025-2030 ($ Millions)
Figure 61. China Restless Legs Syndrome Market Size 2025-2030 ($ Millions)
Figure 62. Japan Restless Legs Syndrome Market Size 2025-2030 ($ Millions)
Figure 63. Korea Restless Legs Syndrome Market Size 2025-2030 ($ Millions)
Figure 64. Southeast Asia Restless Legs Syndrome Market Size 2025-2030 ($ Millions)
Figure 65. India Restless Legs Syndrome Market Size 2025-2030 ($ Millions)
Figure 66. Australia Restless Legs Syndrome Market Size 2025-2030 ($ Millions)
Figure 67. Germany Restless Legs Syndrome Market Size 2025-2030 ($ Millions)
Figure 68. France Restless Legs Syndrome Market Size 2025-2030 ($ Millions)
Figure 69. UK Restless Legs Syndrome Market Size 2025-2030 ($ Millions)
Figure 70. Italy Restless Legs Syndrome Market Size 2025-2030 ($ Millions)
Figure 71. Russia Restless Legs Syndrome Market Size 2025-2030 ($ Millions)
Figure 72. Spain Restless Legs Syndrome Market Size 2025-2030 ($ Millions)
Figure 73. Egypt Restless Legs Syndrome Market Size 2025-2030 ($ Millions)
Figure 74. South Africa Restless Legs Syndrome Market Size 2025-2030 ($ Millions)
Figure 75. Israel Restless Legs Syndrome Market Size 2025-2030 ($ Millions)
Figure 76. Turkey Restless Legs Syndrome Market Size 2025-2030 ($ Millions)
Figure 77. GCC Countries Restless Legs Syndrome Market Size 2025-2030 ($ Millions)
Figure 78. Global Restless Legs Syndrome Market Size Market Share Forecast by Type (2025-2030)
Figure 79. Global Restless Legs Syndrome Market Size Market Share Forecast by Application (2025-2030)
Figure 1. Restless Legs Syndrome Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Restless Legs Syndrome Market Size Growth Rate 2019-2030 ($ Millions)
Figure 6. Restless Legs Syndrome Sales by Geographic Region (2019, 2023 & 2030) & ($ millions)
Figure 7. Restless Legs Syndrome Sales Market Share by Country/Region (2023)
Figure 8. Restless Legs Syndrome Sales Market Share by Country/Region (2019, 2023 & 2030)
Figure 9. Global Restless Legs Syndrome Market Size Market Share by Type in 2023
Figure 10. Restless Legs Syndrome in Below 35 Years Old
Figure 11. Global Restless Legs Syndrome Market: Below 35 Years Old (2019-2024) & ($ Millions)
Figure 12. Restless Legs Syndrome in From 35 to 50 Years Old
Figure 13. Global Restless Legs Syndrome Market: From 35 to 50 Years Old (2019-2024) & ($ Millions)
Figure 14. Restless Legs Syndrome in Above 50 Years Old
Figure 15. Global Restless Legs Syndrome Market: Above 50 Years Old (2019-2024) & ($ Millions)
Figure 16. Global Restless Legs Syndrome Market Size Market Share by Application in 2023
Figure 17. Global Restless Legs Syndrome Revenue Market Share by Player in 2023
Figure 18. Global Restless Legs Syndrome Market Size Market Share by Regions (2019-2024)
Figure 19. Americas Restless Legs Syndrome Market Size 2019-2024 ($ Millions)
Figure 20. APAC Restless Legs Syndrome Market Size 2019-2024 ($ Millions)
Figure 21. Europe Restless Legs Syndrome Market Size 2019-2024 ($ Millions)
Figure 22. Middle East & Africa Restless Legs Syndrome Market Size 2019-2024 ($ Millions)
Figure 23. Americas Restless Legs Syndrome Value Market Share by Country in 2023
Figure 24. United States Restless Legs Syndrome Market Size Growth 2019-2024 ($ Millions)
Figure 25. Canada Restless Legs Syndrome Market Size Growth 2019-2024 ($ Millions)
Figure 26. Mexico Restless Legs Syndrome Market Size Growth 2019-2024 ($ Millions)
Figure 27. Brazil Restless Legs Syndrome Market Size Growth 2019-2024 ($ Millions)
Figure 28. APAC Restless Legs Syndrome Market Size Market Share by Region in 2023
Figure 29. APAC Restless Legs Syndrome Market Size Market Share by Type in 2023
Figure 30. APAC Restless Legs Syndrome Market Size Market Share by Application in 2023
Figure 31. China Restless Legs Syndrome Market Size Growth 2019-2024 ($ Millions)
Figure 32. Japan Restless Legs Syndrome Market Size Growth 2019-2024 ($ Millions)
Figure 33. Korea Restless Legs Syndrome Market Size Growth 2019-2024 ($ Millions)
Figure 34. Southeast Asia Restless Legs Syndrome Market Size Growth 2019-2024 ($ Millions)
Figure 35. India Restless Legs Syndrome Market Size Growth 2019-2024 ($ Millions)
Figure 36. Australia Restless Legs Syndrome Market Size Growth 2019-2024 ($ Millions)
Figure 37. Europe Restless Legs Syndrome Market Size Market Share by Country in 2023
Figure 38. Europe Restless Legs Syndrome Market Size Market Share by Type (2019-2024)
Figure 39. Europe Restless Legs Syndrome Market Size Market Share by Application (2019-2024)
Figure 40. Germany Restless Legs Syndrome Market Size Growth 2019-2024 ($ Millions)
Figure 41. France Restless Legs Syndrome Market Size Growth 2019-2024 ($ Millions)
Figure 42. UK Restless Legs Syndrome Market Size Growth 2019-2024 ($ Millions)
Figure 43. Italy Restless Legs Syndrome Market Size Growth 2019-2024 ($ Millions)
Figure 44. Russia Restless Legs Syndrome Market Size Growth 2019-2024 ($ Millions)
Figure 45. Middle East & Africa Restless Legs Syndrome Market Size Market Share by Region (2019-2024)
Figure 46. Middle East & Africa Restless Legs Syndrome Market Size Market Share by Type (2019-2024)
Figure 47. Middle East & Africa Restless Legs Syndrome Market Size Market Share by Application (2019-2024)
Figure 48. Egypt Restless Legs Syndrome Market Size Growth 2019-2024 ($ Millions)
Figure 49. South Africa Restless Legs Syndrome Market Size Growth 2019-2024 ($ Millions)
Figure 50. Israel Restless Legs Syndrome Market Size Growth 2019-2024 ($ Millions)
Figure 51. Turkey Restless Legs Syndrome Market Size Growth 2019-2024 ($ Millions)
Figure 52. GCC Country Restless Legs Syndrome Market Size Growth 2019-2024 ($ Millions)
Figure 53. Americas Restless Legs Syndrome Market Size 2025-2030 ($ Millions)
Figure 54. APAC Restless Legs Syndrome Market Size 2025-2030 ($ Millions)
Figure 55. Europe Restless Legs Syndrome Market Size 2025-2030 ($ Millions)
Figure 56. Middle East & Africa Restless Legs Syndrome Market Size 2025-2030 ($ Millions)
Figure 57. United States Restless Legs Syndrome Market Size 2025-2030 ($ Millions)
Figure 58. Canada Restless Legs Syndrome Market Size 2025-2030 ($ Millions)
Figure 59. Mexico Restless Legs Syndrome Market Size 2025-2030 ($ Millions)
Figure 60. Brazil Restless Legs Syndrome Market Size 2025-2030 ($ Millions)
Figure 61. China Restless Legs Syndrome Market Size 2025-2030 ($ Millions)
Figure 62. Japan Restless Legs Syndrome Market Size 2025-2030 ($ Millions)
Figure 63. Korea Restless Legs Syndrome Market Size 2025-2030 ($ Millions)
Figure 64. Southeast Asia Restless Legs Syndrome Market Size 2025-2030 ($ Millions)
Figure 65. India Restless Legs Syndrome Market Size 2025-2030 ($ Millions)
Figure 66. Australia Restless Legs Syndrome Market Size 2025-2030 ($ Millions)
Figure 67. Germany Restless Legs Syndrome Market Size 2025-2030 ($ Millions)
Figure 68. France Restless Legs Syndrome Market Size 2025-2030 ($ Millions)
Figure 69. UK Restless Legs Syndrome Market Size 2025-2030 ($ Millions)
Figure 70. Italy Restless Legs Syndrome Market Size 2025-2030 ($ Millions)
Figure 71. Russia Restless Legs Syndrome Market Size 2025-2030 ($ Millions)
Figure 72. Spain Restless Legs Syndrome Market Size 2025-2030 ($ Millions)
Figure 73. Egypt Restless Legs Syndrome Market Size 2025-2030 ($ Millions)
Figure 74. South Africa Restless Legs Syndrome Market Size 2025-2030 ($ Millions)
Figure 75. Israel Restless Legs Syndrome Market Size 2025-2030 ($ Millions)
Figure 76. Turkey Restless Legs Syndrome Market Size 2025-2030 ($ Millions)
Figure 77. GCC Countries Restless Legs Syndrome Market Size 2025-2030 ($ Millions)
Figure 78. Global Restless Legs Syndrome Market Size Market Share Forecast by Type (2025-2030)
Figure 79. Global Restless Legs Syndrome Market Size Market Share Forecast by Application (2025-2030)
